1. Home
  2. ATMU vs SYRE Comparison

ATMU vs SYRE Comparison

Compare ATMU & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atmus Filtration Technologies Inc.

ATMU

Atmus Filtration Technologies Inc.

HOLD

Current Price

$63.98

Market Cap

4.3B

ML Signal

HOLD

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

HOLD

Current Price

$64.21

Market Cap

4.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATMU
SYRE
Founded
1958
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3B
4.0B
IPO Year
2023
2015

Fundamental Metrics

Financial Performance
Metric
ATMU
SYRE
Price
$63.98
$64.21
Analyst Decision
Buy
Strong Buy
Analyst Count
4
9
Target Price
$58.25
$77.78
AVG Volume (30 Days)
1.4M
898.2K
Earning Date
05-01-2026
05-07-2026
Dividend Yield
0.35%
N/A
EPS Growth
12.61
N/A
EPS
2.50
N/A
Revenue
$1,764,300,000.00
N/A
Revenue This Year
$15.00
N/A
Revenue Next Year
$5.13
N/A
P/E Ratio
$25.39
N/A
Revenue Growth
5.67
N/A
52 Week Low
$31.68
$12.04
52 Week High
$66.50
$75.00

Technical Indicators

Market Signals
Indicator
ATMU
SYRE
Relative Strength Index (RSI) 63.10 80.96
Support Level $63.04 $15.23
Resistance Level $66.25 N/A
Average True Range (ATR) 1.90 4.11
MACD 0.78 1.44
Stochastic Oscillator 96.76 66.69

Price Performance

Historical Comparison
ATMU
SYRE

About ATMU Atmus Filtration Technologies Inc.

Atmus Filtration Technologies Inc manufactures filtration products for on-highway commercial vehicles and off-highway agriculture, construction, mining, and power generation vehicles and equipment. The company designs and manufactures Developed filtration products, principally under the Fleetguard brand, that enable lower emissions and provide asset protection. The company designs, manufactures, and sells filters, coolants, and chemical products. The company offers products including air filtration, coolants and chemicals, crankcase ventilation, fuel filtration, fuel cells, lube filtration, and others.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (IBD) and rheumatic diseases. Spyre's pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23 in development as monotherapies and pair-wise combinations. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: